Print Page

Letters to Healthcare Providers
 
Azithromycin and rare risk of cardiovascular death (Letter to Healthcare Professionals)
 
 
 
Attachment:
  1. Azithromycin  
Related Information:
Australia: Azithromycin and rare risk of cardiovascular death Posted 2024-08-02
Canada: Azithromycin (Zithromax® /Zmax SR®) - Risk of Potentially Fatal Cardiac ... Posted 2013-05-18
Singapore: Azithromycin and potential risk of QT prolongation Posted 2013-05-06
The United States: Azithromycin (Zithromax or Zmax): Drug Safety Communication -... Posted 2013-03-13
The United States: Zithromax (azithromycin): FDA Statement on risk of cardiovasc... Posted 2012-05-18
 
back